Temasek Holdings’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Temasek Holdings’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26,803,573	Closed	-$6.83M	–	78
2023 Q1	$6.83M	Hold	26,803,573	–	–	0.04%	54
2022 Q4	$31.6M	Hold	26,803,573	–	–	0.18%	46
2022 Q3	$54.7M	Hold	26,803,573	–	–	0.33%	43
2022 Q2	$41.3M	Hold	26,803,573	–	–	0.23%	47
2022 Q1	$135M	Hold	26,803,573	–	–	0.57%	34
2021 Q4	$166M	Buy	+26,803,573	New	+$239M	0.6%	35

Temasek Holdings's PEAR Position: Q2 2023 in Review

Temasek Holdings sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 26,803,573 shares — an estimated $6.83M sold.

Temasek Holdings first reported a position in PEAR in Q4 2021 and held it in 6 quarters. The position peaked at $166M in Q4 2021. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Temasek Holdings reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Temasek Holdings sold 26,803,573 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $6.83M.
Temasek Holdings first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Temasek Holdings's Pear Therapeutics, Inc. Class A Common Stock position peaked at $166M in Q4 2021.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Temasek Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.